➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Medtronic
McKesson
Boehringer Ingelheim
Merck

Last Updated: January 15, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020489

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

NDA 020489 describes ANDRODERM, which is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. Additional details are available on the ANDRODERM profile page.

The generic ingredient in ANDRODERM is testosterone. There are sixty-nine drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Summary for 020489
Tradename:ANDRODERM
Applicant:Allergan
Ingredient:testosterone
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020489
Mechanism of ActionAndrogen Receptor Agonists
Medical Subject Heading (MeSH) Categories for 020489
Suppliers and Packaging for NDA: 020489
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489 NDA Allergan, Inc. 0023-5990 0023-5990-60 60 POUCH in 1 CARTON (0023-5990-60) > 1 PATCH in 1 POUCH > 1 d in 1 PATCH
ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489 NDA Allergan, Inc. 0023-5992 0023-5992-30 30 POUCH in 1 CARTON (0023-5992-30) > 1 PATCH in 1 POUCH > 1 d in 1 PATCH

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength2.5MG/24HR
Approval Date:Sep 29, 1995TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength5MG/24HR
Approval Date:May 2, 1997TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength2MG/24HR
Approval Date:Oct 20, 2011TE:RLD:Yes

Expired US Patents for NDA 020489

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489-001 Sep 29, 1995   Start Trial   Start Trial
Allergan ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489-002 May 2, 1997   Start Trial   Start Trial
Allergan ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489-002 May 2, 1997   Start Trial   Start Trial
Allergan ANDRODERM testosterone FILM, EXTENDED RELEASE;TRANSDERMAL 020489-002 May 2, 1997   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Johnson and Johnson
McKesson
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.